Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

1.40
Delayed Data
As of Jun 28
 +0.13 / +10.24%
Today’s Change
1.13
Today|||52-Week Range
4.62
-49.56%
Year-to-Date
Merrimack Completes Enrollment in Phase II Study for MM-141
Jun 20 / Zacks.com - Paid Partner Content